While retatrutide may have the best weight loss efficacy to date, analysts hold concerns about its tolerability profile compared with best-seller, tirzepatide.

Kailera Therapeutics is advancing a pipeline of weight loss medicines that mirror that of Eli Lilly’s: an injectable GLP-1/GIP dual agonist like Zepbound, an oral GLP-1 like Foundayo and a triple-G ...

Though the results show competitive efficacy and tolerability, they may leave some observers slightly underwhelmed based on ...

Posting another win for its triple G agonist, Eli Lilly and Co. rolled out top-line phase III data from Triumph-1 showing that all doses of retatrutide met primary and key secondary endpoints for ...

The experimental weight-loss drug is not yet FDA approved, but showed powerful results in a late-stage clinical trial. “This ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

A comprehensive 2026 evaluation uncovering the reality of the Okinawa Salt and Triple G receptor formula, detailing critical ...

Casio’s premium G-Shock MTG-B4000B-1A has started appearing in the U.S. through retailer Arizona Fine Time. The watch is the ...

The Express jumped out to an early lead with a pair of runs in the third. C Jose Herrera doubled, and CF Cam Cauley followed ...

In addition to being state-caliber across the facility and a great meet manager, Kara Deister is also omniscient. In April, during the Ranger Invitational at North, the versatile West Geauga senior ...

The Oneonta girls won a section title, and the boys finished second at the Section IV Class C track and field championships at Newark Valley on Thursday, May 28. The Yellowjacket girls had 97 points ...